WASHINGTON - President Bush's choice to head the Food and Drug Administration is refusing to give Congress all the information it seeks about a controversial antibiotic, setting up further confrontations with a Republican senator blocking his nomination.
The agency's acting chief, Dr. Andrew von Eschenbach, said full disclosure of the information about Ketek could have a chilling effect on the FDA's ability to be an independent and objective evaluator of drug safety and other issues.
The statement came in a written response to questions by Sen. Charles Grassley (news, bio, voting record), R-Iowa. Grassley is blocking Senate confirmation of von Eschenbach while he investigates the FDA's handling of Ketek, which has been linked to severe liver problems and several deaths.
"Selectively providing documents and access to executive agency officials pursuant to a congressional subpoena cannot constitute compliance," Grassley wrote Health and Human Services Secretary Mike Leavitt on Wednesday.
http://news.yahoo.com/s/ap/20061201/ap_on_go_ca_st_pe/fda_von_eschenbach